JPRN-jRCTs031220296已完成未知
A multicenter, open-label, randomized, parallel-group comparative study on the efficacy of Intradialytic parenteral nutrition with ENEFLUID Injection in maintenance hemodialysis patients with malnutrition
Kanno Yoshihiko0 个研究点目标入组 40 人开始时间: 2022年8月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Malnourished maintenance hemodialysis patients with inadequate oral intake
- •(1)Patients aged 20 years or older at the time of informed consent
- •(2)Patients with a nutritional risk index for Japanese hemodialysis patients (NRI-JH) of 5 to 10 within 2 months prior to the start of the study
- •(3)Patients who can obtain informed consent from themselves (Patients who can obtain informed consent from themselves and their regal representatives if their capacity to give informed consent is found to decline)
排除标准
- •(1)Patients who received maintenance hemodialysis for less than 6 months
- •(2)Patients who are contraindicated to receive ENEFLUID Injection
- •(3)Patients who received IDPN within 1 month
- •(4)Patients who are pregnant or wish to become pregnant
- •(5)Patients with type 1 diabetes
- •(6)Patients with severe infection
- •(7)Patients who have been diagnosed and treated for malignant tumors within the past 3 years (excluding basal cell carcinoma of the skin or carcinoma in the uterine cervix which was surgically resected)
- •(8)Patients who with amputation of the lower limbs
- •(9)Patients who deemed ineligible for the study
研究者
相似试验
进行中（未招募）
不适用
Open-label, randomized, active-controlled study of Levetiracetam (LEV) used as monotherapy in patients with Partial-Onset SeizuresEpilepsyPartial SeizuresMedDRA version: 18.1Level: PTClassification code 10015037Term: EpilepsySystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 18.1Level: PTClassification code 10061334Term: Partial seizuresSystem Organ Class: 10029205 - Nervous system disordersEUCTR2015-004586-84-Outside-EU/EEACB Pharma SA436
招募中
3 期
A multicenter, randomized, open-label, parallel-group study of EN-P11 in patients with enteral tube feeding.JPRN-jRCT2021230013Michio Maruyama110
进行中（未招募）
不适用
A randomized, open-label, multicenter, parallel-group study to compare the efficacy, safety and resource utilization of a remifentanil/propofol analgosedation regimen versus a sufentanyl/propofol analgosedation regimen in ventilated patients under intensive medical care with an expected duration of analgosedation of up to 7 daysVentilated patients under intensive medical care with an expected duration of analgosedation of up to 7 daysEUCTR2006-001276-20-DEGlaxoSmithKline GmbH & Co. KG164
进行中（未招募）
不适用
An open-label, randomized, multicenter, parallel-group study to demonstrate correction of anemia using once every four weeks subcutaneous injections of RO0503821 in patients with chronic kidney disease who are not on dialysis - CORDATUSChronic renal anemiaMedDRA version: 8.1Level: LLTClassification code 10058124Term: Nephrogenic anemiaEUCTR2006-001434-41-HUF. Hoffmann-La Roche Ltd300
进行中（未招募）
不适用
An open-label, randomized, multicenter, parallel-group study to demonstrate correction of anemia using once every four weeks subcutaneous injections of RO0503821 in patients with chronic kidney disease who are not on dialysis - CORDATUSEUCTR2006-001434-41-BEF. Hoffmann-La Roche Ltd300